The innovative businessman, Peter Bridger Leads Fortress Investment Group to loan $100 million to the medical company, Theranos to continue their operations throughout 2018 calendar year. Theranos is a medical startup company that was on the verge of bankruptcy and needed capital to continue operations and was happy to announce that Fortress Investment Group would provide them with the necessary loan and financial resources to continue operations and expansion of the organization. Peter Briger Co-Chief Executive Officer of Fortress Investment Group runs the Fortress Credit business and provides analysis and evaluation of opportunities to invest in companies that are underperforming, distressed, and illiquid to provide high levels of returns on investments for the companies over 1750 clients. Peter Briger graduated from Princeton University with a Bachelor of Arts Degree and continued his education by obtaining his Master’s in Business Administration from the Wharton School of Business at the University of Pennsylvania. After college, he pursued an opportunity with Goldman Sachs where he excelled and created a track record of success within the alternative asset investment classes. Peter Briger specialized in global underperforming and distressed investment opportunities within the company where he provided high-level intellectual analysis and evaluation of potential investment opportunities at Goldman Sachs. He quickly became a partner and managing director and helped too exponentially grow their alternative asset investment portfolios.
In 2002, Peter Briger co-founded Fortress Investment Group with five principal partners including Randall Nardone, Wes Edens, Rob Kauffman and Michael Edwards to provide the human capital and intellectual experience to propel the company into a multi-billion dollar investment firm. In fact, in 2007, Fortress Investment Group was the first buyout alternative asset firm to be traded on the New York Stock Exchange where they obtained a lucrative capital influx that propelled them to become one of the more respected and largest investment firms in the world. In 2017, Fortress Investment Group was purchased by SoftBank Group, a global technology company that specializes in Internet services, telecommunications, and various other cutting-edge technology advancements. SoftBank Group continues to provide innovative research and advancement within the technology area that is advancing the world into the information revolution that will provide the infrastructure and necessary advancement to propel the world into the future.
SoftBank purchased Fortress Investment Group for 3.3 billion dollars and continues to grow the alternative investment company by building its portfolio in the alternative asset sector. Fortress Investment Group is one of the leaders in the alternative asset investment category by investing in real estate, credit, private equity, and various other alternative asset instruments And has assets under management well over 30 billion dollars for its International and individual client investors. Fortress provided Theranos a medical startup company with a $100 million loan to stabilize the struggling company and will eventually more than likely reap rewards exponentially from the startup company in the future. Fortress Investment Group specializes in providing resources for distressed, underperforming, and illiquid investment opportunities such as Theranos so they can reap tremendous returns on investment by providing the necessary capital and resources needed in expertise to guide the companies into profitable returns.